Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperthermia, Induced | 15 | 2021 | 510 | 4.430 |
Why?
|
| Cytoreduction Surgical Procedures | 13 | 2021 | 475 | 3.820 |
Why?
|
| Analgesics, Opioid | 7 | 2021 | 1371 | 1.350 |
Why?
|
| Anesthesia | 4 | 2019 | 296 | 1.320 |
Why?
|
| Pain, Postoperative | 4 | 2021 | 610 | 1.070 |
Why?
|
| Anesthesia, Intravenous | 2 | 2016 | 42 | 1.030 |
Why?
|
| Anesthetics | 3 | 2019 | 115 | 0.970 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 6 | 2021 | 169 | 0.910 |
Why?
|
| Perioperative Care | 4 | 2019 | 451 | 0.770 |
Why?
|
| Acute Pain | 1 | 2019 | 42 | 0.680 |
Why?
|
| Tongue Neoplasms | 1 | 2020 | 246 | 0.640 |
Why?
|
| Dexmedetomidine | 1 | 2018 | 85 | 0.610 |
Why?
|
| Blood Transfusion | 2 | 2019 | 583 | 0.610 |
Why?
|
| Analgesia, Epidural | 2 | 2021 | 102 | 0.610 |
Why?
|
| Perioperative Period | 1 | 2018 | 155 | 0.600 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2018 | 126 | 0.590 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2017 | 17 | 0.590 |
Why?
|
| Pain Management | 2 | 2019 | 668 | 0.560 |
Why?
|
| Abdomen | 1 | 2018 | 332 | 0.560 |
Why?
|
| Abdominal Neoplasms | 1 | 2018 | 231 | 0.550 |
Why?
|
| Trachea | 2 | 2021 | 259 | 0.550 |
Why?
|
| Proton Therapy | 3 | 2015 | 1577 | 0.540 |
Why?
|
| Anesthetics, Intravenous | 1 | 2016 | 73 | 0.540 |
Why?
|
| Oximetry | 1 | 2016 | 172 | 0.530 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 206 | 0.530 |
Why?
|
| Carcinoma | 2 | 2017 | 2578 | 0.530 |
Why?
|
| Anesthesia, General | 1 | 2017 | 239 | 0.510 |
Why?
|
| Neoplasms | 8 | 2021 | 15193 | 0.510 |
Why?
|
| Erythrocyte Transfusion | 1 | 2016 | 212 | 0.500 |
Why?
|
| Anesthesiology | 1 | 2016 | 138 | 0.500 |
Why?
|
| Appendiceal Neoplasms | 1 | 2017 | 234 | 0.500 |
Why?
|
| Chronic Pain | 1 | 2018 | 238 | 0.500 |
Why?
|
| Peritoneal Neoplasms | 2 | 2021 | 821 | 0.490 |
Why?
|
| Catheters, Indwelling | 1 | 2016 | 374 | 0.470 |
Why?
|
| Airway Obstruction | 1 | 2017 | 261 | 0.470 |
Why?
|
| Acute Kidney Injury | 2 | 2019 | 739 | 0.450 |
Why?
|
| Skull Base Neoplasms | 1 | 2017 | 314 | 0.440 |
Why?
|
| Cisplatin | 3 | 2019 | 2432 | 0.420 |
Why?
|
| Combined Modality Therapy | 9 | 2021 | 8865 | 0.400 |
Why?
|
| Retrospective Studies | 16 | 2021 | 37905 | 0.400 |
Why?
|
| Radiometry | 1 | 2015 | 980 | 0.360 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 321 | 0.340 |
Why?
|
| Postoperative Complications | 5 | 2019 | 5542 | 0.310 |
Why?
|
| Adolescent | 11 | 2018 | 31252 | 0.300 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2021 | 15862 | 0.280 |
Why?
|
| Male | 18 | 2021 | 123000 | 0.270 |
Why?
|
| Humans | 29 | 2021 | 261506 | 0.250 |
Why?
|
| Female | 18 | 2021 | 141928 | 0.250 |
Why?
|
| Antineoplastic Agents | 6 | 2017 | 14289 | 0.240 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 5437 | 0.240 |
Why?
|
| Child, Preschool | 7 | 2017 | 16273 | 0.230 |
Why?
|
| Child | 10 | 2021 | 29154 | 0.230 |
Why?
|
| Sarcoma | 1 | 2012 | 1725 | 0.200 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 2796 | 0.200 |
Why?
|
| Hemostatic Techniques | 1 | 2021 | 38 | 0.200 |
Why?
|
| One-Lung Ventilation | 1 | 2021 | 9 | 0.190 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 10001 | 0.190 |
Why?
|
| Infant | 4 | 2017 | 13310 | 0.190 |
Why?
|
| Thrombelastography | 1 | 2021 | 79 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 7702 | 0.180 |
Why?
|
| Blood Coagulation Disorders | 1 | 2021 | 120 | 0.180 |
Why?
|
| Middle Aged | 10 | 2021 | 86204 | 0.170 |
Why?
|
| Drug Tolerance | 1 | 2019 | 114 | 0.170 |
Why?
|
| Follow-Up Studies | 6 | 2021 | 14889 | 0.170 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 4298 | 0.160 |
Why?
|
| Mitomycin | 1 | 2019 | 208 | 0.160 |
Why?
|
| Time | 1 | 2018 | 178 | 0.160 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 383 | 0.150 |
Why?
|
| Prognosis | 7 | 2021 | 21713 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2021 | 9244 | 0.150 |
Why?
|
| Subclavian Vein | 1 | 2016 | 35 | 0.150 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 4988 | 0.150 |
Why?
|
| History, 18th Century | 1 | 2016 | 89 | 0.150 |
Why?
|
| Analgesics | 1 | 2019 | 390 | 0.140 |
Why?
|
| Adult | 11 | 2021 | 77950 | 0.140 |
Why?
|
| History, 19th Century | 1 | 2016 | 154 | 0.140 |
Why?
|
| Thoracic Surgery | 1 | 2021 | 295 | 0.140 |
Why?
|
| Survival Analysis | 2 | 2018 | 9180 | 0.140 |
Why?
|
| Intubation, Intratracheal | 2 | 2021 | 445 | 0.140 |
Why?
|
| Propensity Score | 1 | 2019 | 750 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 6207 | 0.140 |
Why?
|
| Young Adult | 7 | 2021 | 21445 | 0.140 |
Why?
|
| Outpatients | 1 | 2019 | 462 | 0.130 |
Why?
|
| Neurofibromatosis 1 | 1 | 2017 | 144 | 0.130 |
Why?
|
| Blood Loss, Surgical | 1 | 2017 | 309 | 0.130 |
Why?
|
| Platelet Count | 1 | 2016 | 490 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2016 | 441 | 0.130 |
Why?
|
| Leukocyte Count | 1 | 2016 | 684 | 0.120 |
Why?
|
| History, 20th Century | 1 | 2016 | 574 | 0.120 |
Why?
|
| Analysis of Variance | 1 | 2017 | 2307 | 0.110 |
Why?
|
| Desmoplastic Small Round Cell Tumor | 1 | 2013 | 86 | 0.110 |
Why?
|
| Reoperation | 1 | 2017 | 1382 | 0.110 |
Why?
|
| Anthracyclines | 1 | 2014 | 331 | 0.110 |
Why?
|
| Aged | 6 | 2021 | 70117 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 3472 | 0.100 |
Why?
|
| Safety | 1 | 2013 | 465 | 0.100 |
Why?
|
| Kidney Function Tests | 1 | 2012 | 192 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2016 | 846 | 0.100 |
Why?
|
| Induction Chemotherapy | 1 | 2015 | 669 | 0.100 |
Why?
|
| Survival Rate | 4 | 2021 | 12221 | 0.100 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2013 | 500 | 0.090 |
Why?
|
| Prevalence | 1 | 2018 | 3260 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2019 | 1225 | 0.090 |
Why?
|
| Length of Stay | 1 | 2016 | 1900 | 0.090 |
Why?
|
| Robotics | 1 | 2013 | 359 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 2315 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2015 | 2803 | 0.080 |
Why?
|
| Brachytherapy | 1 | 2013 | 977 | 0.070 |
Why?
|
| Recurrence | 1 | 2015 | 4758 | 0.070 |
Why?
|
| Disease Progression | 1 | 2017 | 6682 | 0.070 |
Why?
|
| Radiosurgery | 1 | 2013 | 1330 | 0.060 |
Why?
|
| Neoplasm Staging | 3 | 2015 | 13658 | 0.060 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 4975 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 5687 | 0.060 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2021 | 38 | 0.050 |
Why?
|
| Abdominal Muscles | 1 | 2021 | 68 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 2195 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 17523 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 29902 | 0.040 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2021 | 209 | 0.040 |
Why?
|
| Bronchi | 1 | 2021 | 326 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 577 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2021 | 953 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4557 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2015 | 3890 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2016 | 32848 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 10035 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 12873 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 4844 | 0.010 |
Why?
|
OWUSU-AGYEMANG's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(129)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_